Effects of Cholinergic Stimulation with Pyridostigmine Bromide on Chronic Chagasic Cardiomyopathic Mice

Figure 2

Relative cardiac weights after treatment with pyridostigmine bromide. Relative cardiac weights (in mg/g) expressed as mean ± S.E.M. calculated at the 6th month of observation and after one month of treatment (from the 5th to 6th month of infection) in noninoculated control (Con) or in T. cruzi-inoculated (Chg) C57BL/6j mice treated with pyridostigmine bromide (Pyrido) or vehicle (NT: non treated animals). ( versus Con-NT and versus Chg-NT).